Novo, Sanofi Under Investigation for Anti-Competitive Practices in South Africa
The South African Competition Commission is probing Novo Nordisk and Sanofi for anti-competitive practices involving insulin pens. Recent legislation and legislative pressure have prompted significant pricing changes in the insulin …
Novo, Sanofi Under Investigation for Anti-Competitive Practices in South Africa Read More